GSK submits landmark IMPACT data to USFDA for the use of Trelegy Ellipta
Generics | News | 0 Comment | 27 Nov, 2017
Pharma company, GlaxoSmithKline and Innoviva has announced the filing of a supplemental New Drug Application (sNDA) with...Read more
Puma biotech and Specialised Therapeutics signs agreement to commercialize NERLYNX®
Generics | News | 0 Comment | 24 Nov, 2017
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX&r...Read more
Step Pharma completes €14.5 million Series A financing
Generics | News | 0 Comment | 23 Nov, 2017
France based Step Pharma has announced the closing of a Series A financing totalling €14.5 million. Pontifax will ...Read more
FDA approves RxSight's light adjustable lens
Generics | News | 0 Comment | 23 Nov, 2017
Singapore – RxSight (a US based medical devices company) announced that the U.S. Food and Drug Administration (FDA...Read more
PeptiDream announces collaboration with Bayer
Generics | News | 0 Comment | 21 Nov, 2017
Japan based biopharma company PeptiDream Inc. has announced that it has entered into a multi-target discovery collaborat...Read more
Ionis Pharmaceuticals licenses second antisense GI Drug to Janssen
Generics | News | 0 Comment | 17 Nov, 2017
U.S. based Pharma Company Ionis Pharmaceuticals, Inc. has announced that it has licensed a second orally delivered Gener...Read more
Cue Biopharma announces research collaboration with Merck
Generics | News | 0 Comment | 17 Nov, 2017
US based pharma company Cue Biopharma™, Inc. has announced a strategic strategic research collaboration and licens...Read more
Generic Acticlate tablets launched by Lupin in USA
Generics | News | 0 Comment | 06 Nov, 2017
Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg after an approval from ...Read more
Lupin net profit falls 31% in Q2 to Rs 455
Generics | News | 0 Comment | 31 Oct, 2017
Pharma company Lupin reported its financial performance for the second quarter ending September 30th, 2017. The company...Read more
Lupin receives FDA approval for generic Axiron topical solution
Generics | News | 0 Comment | 27 Oct, 2017
Pharma Major Lupin has received final approval for its Testosterone Topical Solution, 30 mg per actuation from the Unite...Read more
Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets
Generics | News | 0 Comment | 27 Oct, 2017
Pharma Major Lupin has announced that it has received final approval for its Carbidopa Tablets, 25 mg and Clonidine Hydr...Read more
US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes
Generics | News | 0 Comment | 23 Oct, 2017
Biopharma company AstraZeneca has announced its US Food and Drug Administration (FDA) approved Bydureon BCise&...Read more
NCD: A major public health challenge for Asia-Pacific
Generics | News | 0 Comment | 11 Oct, 2017
Incidence of non-communicable diseases (NCDs) is on the rise, globally as well as in Asia Pacific region. Implications a...Read more
Lupin receives FDA approval for generic Corgard Tablets
Generics | News | 0 Comment | 10 Oct, 2017
Pharma Major Lupin has announced that it has received final approval for its Nadolol Tablets USP, 20 mg, 40 mg, and 80 m...Read more
"Biomarkers can play a key role in improving diagnosis and disease management of heart failure. "
Generics | Opinion | 2 Comment | 10 Oct, 2017
Singapore - Southeast Asia is home to 9 million heart failure patients. In Singapore alone, it accounts for around 6,000...Read more
Arthritis: Act before it gets Late
Generics | News | 0 Comment | 13 Sep, 2017
Started in 1996, October 12 is recognised as the World Arthritis Day (WAD). Established by Arthritis and Rheumatism Inte...Read more
Michigan third most preferred destination in Midwest for life science investment
Generics | News | 0 Comment | 11 Sep, 2017
Michigan ranked third among 11 Midwest regions for the value of equity investments made in life sciences companies durin...Read more
Eli Lilly to invest more in new medicines and drive growth
Generics | News | 0 Comment | 08 Sep, 2017
Eli Lilly and Company has decided to streamline operations to more efficiently focus resources on developing new medicin...Read more